What Diet Is Most Likely to Help Ease Crohn's Disease?
Title: What Diet Is Most Likely to Help Ease Crohn ' s Disease?Category: Health NewsCreated: 6/8/2021 12:00:00 AMLast Editorial Review: 6/9/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - June 9, 2021 Category: Nutrition Source Type: news

What Diet Is Most Likely to Help Ease Crohn's Disease?
TUESDAY, June 8, 2021 -- People who have Crohn ' s disease often seek to ease their symptoms by changing what they eat, and new research suggests the Mediterranean diet may be their best bet. The study evaluated one of the commonly used diets for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 8, 2021 Category: General Medicine Source Type: news

AGA Issues Recommendations for Moderate-to-Severe Crohn Disease
FRIDAY, June 4, 2021 -- In clinical practice guidelines from the American Gastroenterological Association (AGA) published in the June 1 issue of Gastroenterology, recommendations are presented for the management of moderate-to-severe luminal and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 4, 2021 Category: Pharmaceuticals Source Type: news

What Are Best Foods to Eat with Crohn's Disease
What Are the Best Foods to Eat with Crohn ' s Disease? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 4, 2021 Category: General Medicine Source Type: news

What Are the Warning Signs of Crohns Disease
What Are the Warning Signs of Crohn ’s Disease? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 4, 2021 Category: General Medicine Source Type: news

SEAVUE: Ustekinumab vs Adalimumab for Crohn's Disease SEAVUE: Ustekinumab vs Adalimumab for Crohn's Disease
For biologic-naive adults with moderate to severe Crohn ' s disease, treatment with either adalimumab or ustekinumab leads to similar outcomes, according to results of the head-to-head SEAVUE trial.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 28, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

'Good' bacteria show promise for clinical treatment of Crohn's disease, ulcerative colitis
(University of North Carolina Health Care) Balfour Sartor, MD, Midget Distinguished Professor of Medicine, Microbiology and Immunology, is the senior author of a study that shows how a novel consortium of bacteria that live in the digestive tracts of healthy individuals can be used to prevent and treat aggressive colitis in humanized mouse models. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 28, 2021 Category: International Medicine & Public Health Source Type: news

Janssen Presents Results of First Head-to-Head Study of Biologic Therapies in Patients with Moderate to Severe Crohn ’s Disease
SPRING HOUSE, PENNSYLVANIA, May 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced efficacy and safety data for STELARA® (ustekinumab) in Crohn’s disease (CD) and ulcerative colitis (UC),1-4including data from the SEAVUE study, the first head-to-head study of biologic therapies in patients with CD, presented in a Clinical Science Late-Breaking Abstract Plenary session.1 SEAVUE data showed treatment with STELARA demonstrated high rates of clinical remission, corticosteroid-free remission, clinical response and endoscopic response through one year in biologic-naïve patients with mo...
Source: Johnson and Johnson - May 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

VENUS: Ustekinumab Superior to Vedolizumab for Refractory Crohn's VENUS: Ustekinumab Superior to Vedolizumab for Refractory Crohn's
A study directly compares two biologic agents among patients with Crohn ' s disease who failed previous anti-TNF therapy.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 21, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

VENUS: Ustekinumab Appears Superior to Vedolizumab for Crohn's VENUS: Ustekinumab Appears Superior to Vedolizumab for Crohn's
A retrospective analysis compares two biologic agents among patients with Crohn ' s disease who failed previous anti-TNF therapy.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 21, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

2001 to 2018 Saw Increase in Estimated Prevalence of IBD in Seniors
THURSDAY, May 13, 2021 -- During 2001 to 2018, the overall estimated prevalence of Crohn disease and ulcerative colitis increased among Medicare fee-for-service beneficiaries, with a higher increase seen among non-Hispanic Blacks, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 13, 2021 Category: Pharmaceuticals Source Type: news

Crohn's disease patients have specific IgG antibodies to human bacterial flagellins
(University of Alabama at Birmingham) Last year, researchers used a mouse model that included immune-reactive T cells from patients with Crohn's disease in a proof-of-principle demonstration that a flagellin-directed immunotherapy might provide similar benefits in patients. Now they have moved a step closer to possible clinical testing of this treatment, with a study, published in the journal Gastroenterology, that is the first to describe IgG antibodies in Crohn's disease specific for human-derived flagellins of bacteria in the Lachnospiraceae family. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 5, 2021 Category: International Medicine & Public Health Source Type: news

Crohn's and Colitis Care in the UK: The Hidden Cost and a Vision for Change
This report reveals variation in care across services, and highlights key actions urgently needed, including improvements in information provision, faster access to specialist care, and ensuring every IBD service is resourced to meet the staffing requirements for the IBD team. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 4, 2021 Category: Consumer Health News Source Type: news

Is Crohn ’s Disease a Disability?
Title: Is Crohn ’s Disease a Disability?Category: Diseases and ConditionsCreated: 4/30/2021 12:00:00 AMLast Editorial Review: 4/30/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - April 30, 2021 Category: Nutrition Source Type: news

Crohn ’s Disease Is on the Rise
Many think the abdominal disorder starts in childhood, but it can occur at any age and is becoming more prevalent throughout the world. (Source: NYT Health)
Source: NYT Health - April 26, 2021 Category: Consumer Health News Authors: Jane E. Brody Tags: Crohn ' s Disease Bowels Drugs (Pharmaceuticals) Digestive Tract Colon Source Type: news